Drug Discovery Summit26 - 27 October 2021 | London, UK
An invaluable resource for those looking to improve efficiency, increase pipelines and keep up to date with the latest advances. Featuring key insights into protein degradation, AI/ML in drug discovery, and much more
The Drug Discovery Summit features...
Over 400 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions
A look at the future of drug discovery in new modalities such as protein degradation, RNA based therapeutics and case studies on the identification and Validation of Novel Targets
The latest updates on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling, and novel RNA drug targets
Insights into drug discovery strategies & next generation therapeutics, empowering drug discovery with chemical biology, target validation, drug profiling and protein degradation technologies
An evaluation of the Development of Clinical Biomarker translation and patient engagement
Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features
Agenda at a Glance
Day One
Morning Sessions:
Stream 1: Identification and Validating Novel Targets – Case Study Presentations
Stream 2: Phenotypic Based Discovery & Screening Approaches
Stream 3: New Modalities And Challenging Targets: Targeted Protein Degradation and PROTAC
Afternoon Interactive Sessions:
Roundtable Discussions:
– Identification and Validating Novel Targets
– New Modalities And Challenging Targets: Targeted Protein Degradation & PROTAC
Workshops:
– Molecular Glue for New Drug Development Workshop
– E3 Ubiquitin Ligases and Targeted Protein Degradation
– Overview Of Available Methods To Characterize The Compound – Target Interaction On A Molecular Level Via SPR, MST, ITC and TSA
Day Two
Morning Sessions:
Stream 1: New Modalities And Challenging Targets: RNA based Therapeutics
Stream 2: Animal and Disease Modelling, Organoid based Discovery, 3D Media
Afternoon Interactive Sessions:
Roundtable Discussions:
– Target Discovery and Animal Modelling
– Translational Biomarkers and Patient Engagement
Workshop: Development And Identification Of Biomarkers, New Targets And Combination Therapies For Cancer
Key Speakers
The 2021 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Jake Bush
Eric Martin
Phil Cox
Ian Storer
Malcolm Weir
Thorsten Thormann
Janet Brownlees
Sarah Stuart
Bryn Williams-Jones
